The Inserm Cross-Cutting Program on Microbiota will come to an end in 2024. For this occasion, a final symposium will be held on October 28th and 29th 2024 at the Université Paris Cité. This scientific meeting will be an opportunity to present the work carried out during the program and to highlight the role of the microbiota in health. You will find here all the information concerning the symposium, as well as the registration and poster abstract submission forms.

The registration for the symposium is free but mandatory before September 15^th 2024.

Over the last 20 years, a growing body of research has explored the complexity of microbial communities living in symbiosis with their hosts and their importance for health. In particular, it has shed light on the gut microbiota showing how the many beneficial effects of the symbiosis established between humans and their gut bacteria have been compromised over the last 50 years by environmental and dietary changes associated with industrialisation. Importantly, alterations in the gut ecosystem are now considered to be a major contributor to the global “epidemic” of chronic inflammatory and metabolic diseases.

To better understand the role of the microbiota in human health and pathology, Inserm launched in 2017 a dedicated multidisciplinary program gathering twenty scientific teams. This program has focused on finding causal links between changes in the microbiota and disease, in particular by studying the metabolic pathways affected by changes in the microbiota and by studying the gut ecosystem.

This final symposium provides the opportunity to present the work carried out during the program and leap into the future with the “Food Systems, Microbiomes and Health Research Program” (PEPR SAMS), funded as part of the France 2030 investment plan, that is taking over to support a national effort in this area of research.

https://pro.inserm.fr/evenements/inserm-symposium-on-microbiota